Zobrazeno 1 - 10
of 1 484
pro vyhledávání: '"Daley, H."'
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Autor:
Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Graham CE; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Ritchey J; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Horick NK; Department of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA., El-Jawahri A; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Haradhvala NJ; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA., Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Lee WH; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Parker AL; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Wiggin HR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Bouffard A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Dey A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Katsis K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Elder EL; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Dolaher MA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Cook DT; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Chekmasova AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Huang L; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Nikiforow S; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Daley H; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Armant M; TransLab, Boston Children's Hospital, Boston, MA., Preffer F; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., DiPersio JF; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Nardi V; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Gallagher KME; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1153-1167.
Autor:
Sîrbulescu RF; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nicholson K; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kawai K; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hilton OM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sobell D; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jin G; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Verrill DE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Dwyer LJ; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Xiong Y; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bachanová P; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kim SE; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gallup S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gelevski D; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Daley H; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hernandez Rodriguez DE; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Negre H; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sturtevant O; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nikiforow S; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ritz J; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chen YB; The Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Berry JD; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sadri-Vakili G; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Cudkowicz M; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Sean M. Healey and AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; The Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Jul 15; Vol. 38 (13), pp. e23796.
Autor:
Sussman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Severgnini M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Clinical Sciences, Curis, Inc., Lexington, MA, United States., Giobbie-Hurder A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States., Friedlander P; Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Swanson SJ; Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States., Jaklitsch M; Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States., Clancy T; Department of Surgery, Brigham and Women's Hospital, Boston, MA, United States., Goguen LA; Division of Otolaryngology, Brigham and Women's Hospital, Boston, MA, United States., Lautz D; Department of Surgery, Emerson Hospital, Concord, MA, United States., Swanson R; Department of Surgery, UMass Chan Medical School, Worcester, MA, United States., Daley H; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, United States., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, United States., Dranoff G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 May 15; Vol. 14, pp. 1395978. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).
Autor:
Hoskins NN; Obstetrics and Gynecology, Reading Hospital, West Reading, USA., Daley H; Obstetrics and Gynecology, Drexel University College of Medicine, West Reading, USA., Cunicelli MA; Family Medicine, Lancaster General Hospital, Lancaster, USA.
Publikováno v:
Cureus [Cureus] 2024 Apr 18; Vol. 16 (4), pp. e58527. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jurkunas UV; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Yin J; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Johns LK; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Li S; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Negre H; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Shaw KL; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Samarakoon L; Jaeb Center for Health Research, Tampa, FL, USA., Ayala AR; Jaeb Center for Health Research, Tampa, FL, USA., Kheirkhah A; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Katikireddy K; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Gauthier A; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Ong Tone S; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Kaufman AR; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Ellender S; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Hernandez Rodriguez DE; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Daley H; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA., Dana R; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Armant M; TransLab, Translational Research Program, Boston Children's Hospital, Boston, MA, USA., Ritz J; Connell and O'Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Science advances [Sci Adv] 2023 Aug 18; Vol. 9 (33), pp. eadg6470. Date of Electronic Publication: 2023 Aug 18.
Autor:
Frigault MJ; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Bishop MR; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA., O'Donnell EK; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Raje N; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Cook D; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Yee AJ; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Logan E; Beth Israel Deaconess Medical Center, Boston, MA., Avigan DE; Beth Israel Deaconess Medical Center, Boston, MA., Jakubowiak A; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Shaw K; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA., Daley H; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA., Nikiforow S; Dana Farber Cancer Institute, Cell Manipulation Core Facility, Brookline, MA., Griffin F; Arcellx, Inc., Gaithersburg, MD., Cornwell C; Arcellx, Inc., Gaithersburg, MD., Shen A; Arcellx, Inc., Gaithersburg, MD., Heery C; Arcellx, Inc., Gaithersburg, MD., Maus MV; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Mar 14; Vol. 7 (5), pp. 768-777.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Cytotherapy 2006 8(4):399-407